Phe-308 and Phe-312 in transmembrane domain 7 are major sites of a1-adrenergic receptor antagonist binding. Imidazoline agonists bind like antagonists
Waugh, D.J.J.; Gaivin, R.J.; Zuscik, M.J.
Journal of Biological Chemistry 276(27): 366-371
2001
ISSN/ISBN: 0021-9258
Accession: 018050368
PDF emailed within 1 workday: $29.90
Related References
Waugh, D.J.; Gaivin, R.J.; Zuscik, M.J.; Gonzalez-Cabrera, P.; Ross, S.A.; Yun, J.; Perez, D.M. 2001: Phe-308 and Phe-312 in transmembrane domain 7 are major sites of alpha 1-adrenergic receptor antagonist binding. Imidazoline agonists bind like antagonists Journal of Biological Chemistry 276(27): 25366-25371Takahashi, K.; Hossain, M.; Ahmed, M.; Bhuiyan, M.A.; Ohnuki, T.; Nagatomo, T. 2007: Asp125 and Thr130 in transmembrane domain 3 are major sites of alpha1b-adrenergic receptor antagonist binding Biological and Pharmaceutical Bulletin 30(10): 1891-1894
Piletz, J.E.; Halaris, A. 1984: Modulation of binding by guanine nucleotide suggests that antagonists and agonists bind to different forms of an alpha 2 adrenergic receptor on human platelets Society for Neuroscience Abstracts 10(1): 280
Turcatti, G.; Vogel, H.; Chollet, A. 1995: Probing the Binding Domain of the NK2 Receptor with Fluorescent Ligands: Evidence That Heptapeptide Agonists and Antagonists Bind Differently Biochemistry 34(12): 3972-3980
Root-Bernstein, R.; Turke, M.; Subhramanyam, U.K.T.; Churchill, B.; Labahn, J. 2018: Adrenergic Agonists Bind to Adrenergic-Receptor-Like Regions of the Mu Opioid Receptor, Enhancing Morphine and Methionine-Enkephalin Binding: a new Approach to "Biased Opioids"? International Journal of Molecular Sciences 19(1)
King, P.R.; Suzuki, S.; Hosseini, A.R.; Iakovidis, D.; Nero, T.L.; Jackman, G.P.; Louis, W.J.; Gundlach, A.L. 1998: [3H]Rilmenidine-labelled imidazoline-receptor binding sites co-localize with [3H]2-(benzofuranyl)-2-imidazoline-labelled imidazoline-receptor binding sites and monoamine oxidase-B in rabbit, but not rat, kidney Imidazoline Receptor Workshop 72(2-3): 118-128
King, P.R.; Suzuki, S.; Hosseini, A.R.; Iakovidis, D.; Nero, T.L.; Jackman, G.P.; Louis, W.J.; Gundlach, A.L. 1998: 3H]Rilmenidine-labelled imidazoline-receptor binding sites co-localize with [3H]2-(benzofuranyl)-2-imidazoline-labelled imidazoline-receptor binding sites and monoamine oxidase-B in rabbit, but not rat, kidney Journal of the Autonomic Nervous System 72(2-3): 118-128
King, P.R.; Suzuki, S.; Hosseini, A.R.; Iakovidis, D.; Nero, T.L.; Jackman, G.P.; Louis, W.J.; Gundlach, A.L. 1998: Rilmenidine-labelled imidazoline-receptor binding sites co-localize with 2- -2-imidazoline-labelled imidazoline-receptor binding sites and monoamine oxidase-B in rabbit, but not rat, kidney Journal of the Autonomic Nervous System 72(2-3): 118-128
Fagg, G.E.; Baud, J.; Hall, R.; Dingwall, J. 1988: Do agonists and competitive antagonists bind to distinct sites on the nmda receptor Cavalheiro, E A , J Lehmann And L Turski (Ed ) Neurology And Neurobiology, Vol 46 Frontiers in Excitatory Amino Acid Research; International Symposium Excitatory Amino Acids '88, Manaus, Amazonas, Brazil, March 28-April 2, Xxxvi+745p Alan R Liss, Inc : New York, New York, Usa Illus 59-66
Botana, L.M. 1987: Adrenergic agonists do not compete with the antagonist (-)3-[125I]iodocyanopindolol for binding to rat pleural or peritoneal mast cell adrenergic receptor General Pharmacology 18(3): 263-267
Giorgioni, G.; Ambrosini, D.; Vesprini, C.; Hudson, A.; Nasuti, C.; Di Stefano, A.; Sozio, P.; Ciampi, O.; Costa, B.; Martini, C.; Carrieri, A.; Carbonara, G.; Enzensperger, C.; Pigini, M. 2010: Novel imidazoline compounds as partial or full agonists of D2-like dopamine receptors inspired by I2-imidazoline binding sites ligand 2-BFi Bioorganic and Medicinal Chemistry 18(19): 7085-7091
Botana, L.M. 1987: Adrenergic agonists do not compete with the antagonist iodine 125 levo 3 iodocyanopindolol for binding to rat pleural or peritoneal mast cell adrenergic receptor General Pharmacology 18(3): 263-268
Wurch, T.; Colpaert, F.C.; Pauwels, P.J. 1998: Chimeric receptor analysis of the ketanserin binding site in the human 5-Hydroxytryptamine1D receptor: importance of the second extracellular loop and fifth transmembrane domain in antagonist binding Molecular Pharmacology 54(6): 1088-1096
Raasch, W.; Chun KRJ; Dendorfer, A.; Dominiak, P. 2000: Positive inotropic effects of imidazoline derivatives are not mediated via imidazoline binding sites but alpha1-adrenergic receptors Japanese Journal of Pharmacology 84(1): 1-6
Josephs, T.M.; Keller, A.N.; Khajehali, E.; DeBono, A.; Langmead, C.J.; Conigrave, A.D.; Capuano, B.; Kufareva, I.; Gregory, K.J.; Leach, K. 2020: Negative allosteric modulators of the human calcium-sensing receptor bind to overlapping and distinct sites within the 7-transmembrane domain British Journal of Pharmacology 177(8): 1917-1930